PRF will host a webinar with Luana Colloca, University of Maryland School of Nursing, and School of Medicine, Baltimore, US, on Wednesday, April 26, 12 p.m.-1:30 p.m., US Eastern Daylight Time/5-6:30 p.m. GMT/6-7:30 p.m. CET.
(Click here to see the time zone conversion for your country)
Attendance is free, but registration is required. Register now.
Colloca will discuss placebo and nocebo effects in pain research. After her talk, there will be a panel discussion featuring:
- Javeria Ali Hashmi, Dalhousie University, Halifax, Nova Scotia, Canada
- Marta Pecina, University of Pittsburgh, US
- Tor Wager, University of Colorado Boulder, US (moderator)
Audience participation is encouraged! During the live discussion, participants will be able to submit questions to the panel. You can also submit questions now, by emailing them to firstname.lastname@example.org.
Here is an abstract of Colloca’s talk:
Expectancies produce positive outcomes and placebo effects in individuals by virtue of anticipations of a benefit and activation of specific endogenous modulatory systems. Based on a well-established proposed conceptual framework, placebo effects will be presented as the product of expectancy mechanisms in which conditioned, verbal, and observational cues are centrally integrated to change behaviors and outcomes. Neuroimaging studies that have capitalized on well-established behavioral paradigms within this framework implicate the dorsolateral prefrontal cortex as a key region in producing these effects. However, expectancies of improvements in real-world settings are often violated. The effects of expectancy violation will be presented along with the brain mechanism implicated in mismatch processing and abolishment of placebo effects. Strategies to harness placebo effects will also be discussed, including the use of dose-extending placebos as well as vasopressin as potential promising adjuvants contributing to the enhancement of placebo effects.
Moreover, providers’ behaviors, environmental cues, and the appearance of medical devices can induce nocebo effects that dramatically influence clinical outcomes in pain patients. The anticipation of negative outcomes engages a complex set of neural circuits along with biochemical changes both in peripheral tissues and in the central nervous system, resulting in the occurrence and/or worsening of clinical pain outcomes.Nocebo effects are formed through anticipation of adverse events, prior unsuccessful therapeutic experiences, and observation of adverse events in others. Knowledge of the mechanisms of nocebo effects can definitely be valuable for daily clinical practice.
- To present how placebo and nocebo effects are formed in the context of pain research
- To identify the mechanisms underlying learning and violation of reinforced expectations, with the scope for exploiting knowledge of placebo effects and endogenous pain modulatory systems and minimizing nocebo effects
See previous PRF webinars here.